Endoscopic Bariatrics: Current Therapies and Future Directions

Overview

Journal Transl Gastroenterol Hepatol

Publisher AME Publishing Company

Specialty Gastroenterology

Date 2022 May 13

PMID 35548475

Authors

Debashis Reja

Clark Zhang

Avik Sarkar

Affiliations

Soon will be listed here.

Abstract

Endoscopic bariatric therapies (EBTs) are endoscopic procedures indicated for weight loss in the obese population. They are shown to be safe and effective for patients who do not quality for bariatric surgery. There are currently no randomized controlled studies comparing bariatric surgery with EBTs. However, EBTs are more cost effective and have fewer complications. This review will examine currently available EBTs with published data.

Citing Articles

The Risk of Leakage and Bleeding After Using the Ezisurg Endostapler Technique for Bariatric Surgery.

Alhroot M, Hassanat R, Albadaina A, Alqaisi Q, Altamimi A, Aldaileh M Cureus. 2025; 16(12):e75695.

PMID: 39811224 PMC: 11729792. DOI: 10.7759/cureus.75695.

Intragastric botulinum toxin injection for weight loss: current trends, shortcomings and future perspective.

Arabpour E, Golmoradi H, Tape P, Sadeghi A, Abdehagh M, Moghadam P Clin Endosc. 2024; 58(1):10-24.

PMID: 39722145 PMC: 11837562. DOI: 10.5946/ce.2024.153.

Phenotyping of Obesity Treatment Candidates: A Narrative Review.

Sherf-Dagan S, Refaeli R, Buch A Curr Obes Rep. 2024; 13(3):564-573.

PMID: 38874701 DOI: 10.1007/s13679-024-00576-x.

Overview on the endoscopic treatment for obesity: A review.

Abdulla M, Mohammed N, AlQamish J World J Gastroenterol. 2023; 29(40):5526-5542.

PMID: 37970474 PMC: 10642436. DOI: 10.3748/wjg.v29.i40.5526.

References

Espinos J, Turro R, Moragas G, Bronstone A, Buchwald J, Mearin F . Gastrointestinal Physiological Changes and Their Relationship to Weight Loss Following the POSE Procedure. Obes Surg. 2015; 26(5):1081-9. DOI: 10.1007/s11695-015-1863-8. View

Brooks J, Srivastava E, Mathus-Vliegen E . One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes Surg. 2014; 24(5):813-9. DOI: 10.1007/s11695-014-1176-3. View

Rohde U, Federspiel C, Vilmann P, Langholz E, Friis S, Krakauer M . The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes. Diabetes Obes Metab. 2016; 19(2):189-199. DOI: 10.1111/dom.12800. View

Al-Subaie S, Khalifa S, Buhaimed W, Al-Rashidi S . A prospective pilot study of the efficacy and safety of Elipse intragastric balloon: A single-center, single-surgeon experience. Int J Surg. 2017; 48:16-22. DOI: 10.1016/j.ijsu.2017.10.001. View

AlSabah S, Al Haddad E, Ekrouf S, Almulla A, Al-Subaie S, Al Kendari M . The safety and efficacy of the procedureless intragastric balloon. Surg Obes Relat Dis. 2018; 14(3):311-317. DOI: 10.1016/j.soard.2017.12.001. View

Shahnazarian V, Ramai D, Sarkar A . Endoscopic bariatric therapies for treating obesity: a learning curve for gastroenterologists. Transl Gastroenterol Hepatol. 2019; 4:16. PMC: 6458346. DOI: 10.21037/tgh.2019.03.01. View

Thompson C, Abu Dayyeh B, Kushner R, Sullivan S, Schorr A, Amaro A . Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. Am J Gastroenterol. 2016; 112(3):447-457. PMC: 5350543. DOI: 10.1038/ajg.2016.500. View

Sullivan S, Edmundowicz S, Thompson C . Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies. Gastroenterology. 2017; 152(7):1791-1801. DOI: 10.1053/j.gastro.2017.01.044. View

Turkeltaub J, Edmundowicz S . Endoscopic Bariatric Therapies: Intragastric Balloons, Tissue Apposition, and Aspiration Therapy. Curr Treat Options Gastroenterol. 2019; 17(2):187-201. DOI: 10.1007/s11938-019-00232-7. View

10.

Machytka E, Klvana P, Kornbluth A, Peikin S, Mathus-Vliegen L, Gostout C . Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg. 2011; 21(10):1499-507. PMC: 3179587. DOI: 10.1007/s11695-011-0424-z. View

11.

Yorke E, Switzer N, Reso A, Shi X, de Gara C, Birch D . Intragastric Balloon for Management of Severe Obesity: a Systematic Review. Obes Surg. 2016; 26(9):2248-2254. DOI: 10.1007/s11695-016-2307-9. View

12.

Courcoulas A, Abu Dayyeh B, Eaton L, Robinson J, Woodman G, Fusco M . Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. Int J Obes (Lond). 2016; 41(3):427-433. DOI: 10.1038/ijo.2016.229. View

13.

van Baar A, Holleman F, Crenier L, Haidry R, Magee C, Hopkins D . Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study. Gut. 2019; 69(2):295-303. PMC: 6984054. DOI: 10.1136/gutjnl-2019-318349. View

14.

Thompson C, Abu Dayyeh B, Kushnir V, Kushner R, Jirapinyo P, Schorr A . Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial. Surg Obes Relat Dis. 2019; 15(8):1348-1354. DOI: 10.1016/j.soard.2019.04.026. View

15.

Russo T, Aprea G, Formisano C, Ruggiero S, Quarto G, Serra R . BioEnterics Intragastric Balloon (BIB) versus Spatz Adjustable Balloon System (ABS): Our experience in the elderly. Int J Surg. 2016; 38:138-140. DOI: 10.1016/j.ijsu.2016.06.013. View

16.

Vargas E, Pesta C, Bali A, Ibegbu E, Bazerbachi F, Moore R . Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population. Clin Gastroenterol Hepatol. 2018; 16(7):1073-1080.e1. PMC: 6008169. DOI: 10.1016/j.cgh.2018.01.046. View

17.

Espinet-Coll E, Nebreda-Duran J, Gomez-Valero J, Munoz-Navas M, Pujol-Gebelli J, Vila-Lolo C . Current endoscopic techniques in the treatment of obesity. Rev Esp Enferm Dig. 2012; 104(2):72-87. DOI: 10.4321/s1130-01082012000200006. View

18.

Badurdeen D, Kumbhari V . Endoscopic sleeve gastroplasty and its application to China. J Dig Dis. 2017; 18(10):551-555. DOI: 10.1111/1751-2980.12547. View

19.

Miller K, Turro R, Greve J, Bakker C, Buchwald J, Espinos J . MILEPOST Multicenter Randomized Controlled Trial: 12-Month Weight Loss and Satiety Outcomes After pose vs. Medical Therapy. Obes Surg. 2016; 27(2):310-322. DOI: 10.1007/s11695-016-2295-9. View

20.

Ma I, Madura 2nd J . Gastrointestinal Complications After Bariatric Surgery. Gastroenterol Hepatol (N Y). 2016; 11(8):526-35. PMC: 4843041. View